Pulmonary embolism and diffuse alveolar bleeding: combination options and therapy features
- 作者: Tret’yakov A.1, Radenska-Lopovok S.2,3, Novikov P.2, Tret’yakova V.4, Zakharchenko S.1
-
隶属关系:
- Belgorod National Research University
- Sechenov First Moscow State Medical University (Sechenov University)
- Russian Medical Academy of Continuous Professional Education
- People’s Friendship University of Russia
- 期: 卷 93, 编号 3 (2021)
- 页面: 311-319
- 栏目: Reviews
- URL: https://journals.rcsi.science/0040-3660/article/view/64975
- DOI: https://doi.org/10.26442/00403660.2021.03.200657
- ID: 64975
如何引用文章
全文:
详细
The analysis of the mechanisms of the formation of a rare clinical combination of pulmonary embolism (PE) and diffuse alveolar hemorrhage (DAH), which are complications of systemic vasculitis associated with antibodies to the cytoplasm of neutrophils (primarily granulomatosis with polyangiitis), systemic lupus erythematosus and secondary antiphlogistic syndrome – primary antiphospholipid syndrome and Goodpasture’s syndrome. Taking into account the chronological sequence of the occurrence of PE and DAH, 3 variants of the onset of these potentially fatal additions to the underlying disease were considered: the anticipatory DAH development of PE, delayed from DAH PE and joint (within 24 hours) formation of PE and DAH. A review of single descriptions of such a combination of complications of granulomatosis with polyangiitis is carried out, criteria are indicated, a working classification of severity is given and, taking this into account, a modern program of therapy for DAH as an independent event and in combination with PE.
作者简介
Andrey Tret’yakov
Belgorod National Research University
编辑信件的主要联系方式.
Email: opensource2007@yandex.ru
ORCID iD: 0000-0001-8489-3851
д.м.н, проф., проф. Медицинского института ФГАОУ ВПО БГНИУ
俄罗斯联邦, BelgorodStefka Radenska-Lopovok
Sechenov First Moscow State Medical University (Sechenov University); Russian Medical Academy of Continuous Professional Education
Email: opensource2007@yandex.ru
ORCID iD: 0000-0002-4669-260X
д.м.н, проф., проф. каф. патологической анатомии им. акад. А.И. Струкова ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет), проф. каф. патологической анатомии ФГБОУ ДПО РМАНПО
俄罗斯联邦, Moscow; MoscowPavel Novikov
Sechenov First Moscow State Medical University (Sechenov University)
Email: opensource2007@yandex.ru
ORCID iD: 0000-0003-0148-5655
к.м.н., зав. ревматологическим отд-нием №1 клиники им. Е.М. Тареева УКБ №3 ФГАОУ ВО «Первый МГМУ им. И.М. Сеченова» (Сеченовский Университет)
俄罗斯联邦, MoscowViktoriia Tret’yakova
People’s Friendship University of Russia
Email: opensource2007@yandex.ru
ORCID iD: 0000-0002-8990-3470
аспирант каф. внутренних болезней с курсом кардиологии и функциональной диагностики ФГАОУ ВО РУДН
俄罗斯联邦, MoscowSvetlana Zakharchenko
Belgorod National Research University
Email: openbox.2013@yandex.ru
к.м.н, ст. науч. сотр. Медицинского института ФГАОУ ВПО БГНИУ
俄罗斯联邦, Belgorod参考
- Allenbach Y, Seror R, Pagnoux C, et al. High frequency of venous thromboembolic events in Churg-Strauss syndrome, Wegener’s granulomatosis and microscopic polyangiitis but not polyarteritis nodosa: a systematic retrospective study on 1130 patients. Ann Rheum Dis. 2009;68(4):564-7. doi: 10.1136/ard.2008.099051
- Hammoudeh F, Perwaiz MK, Patolia S, et al. Diffuse Alveolar Haemorrhage with ANCA associated vaculitis – review of literature. Br J Med Practition. 2011;4(1):16-9.
- Ahlehoff O, Wu JJ, Raunsø J. Cutaneous lupus erythematosus and the risk of deep venous thrombosis and pulmonary embolism: A Danish nationwide cohort study. Lupus. 2017;26(13):1435-9.doi: 10.1177/0961203317716306
- Isshiki Т, Sugino K, Gocho K, et al. Primary Antiphospholipid Syndrome Associated with Diffuse Alveolar Hemorrhage and Pulmonary Thromboembolism. Intern Med. 2015;54(16):2029-33.doi: 10.2169/internalmedicine.54.4058
- Moreno-Gonzalez G, Corral-Ansa L, Sabater-Riera J, et al. Pulmonary Thromboembolism and Diffuse Alveolar Hemorrhage in Granulomatosis With Polyangiitis Vasculitis. Respiratory Care. 2014;59(12):206-9.doi: 10.4187/respcare.03162
- Kazzaz NM, Coit P, Lewis EE, Knight JS. Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival. Lupus Sci Med. 2015;2(1):000117.doi: 10.1136/lupus-2015-000117
- Bazzan M, Vaccarino A, Marletto F. Systemic lupus erythematosus and thrombosis. Thrombosis J. 2015;13:16. doi: 10.1186/s12959-015-0043-3
- Мухин Н.А., Семенкова Е.Н., Кривошеев О.Г., Новиков П.И. Применение ритуксимаба при тяжелых АНЦА-ассоциированных системных васкулитах. Клиническая нефрология. 2010;2:40-5 [Mykhin NA, Semencova EN, Krivosheev OG, Novikov PI. Use of rituximab for severe ANCA-associated systemic vasculitis. Klinicheskaya nefrologiya. 2010;2:40-5 (In Russ.)].
- Thickett DR, Richter AG, Nathani N, et al. Pulmonary manifestations of anti-neutrophil cytoplasmic antibody (ANCA)-positive vasculitis. Rheumatology. 2006;45(3):261-8. doi: 10.1093/rheumatology/kei217
- Stassen PM, Derks RP, Kallenberg CG. Venous thromboembolism in ANCA-associated vasculitis-incidence and risk factors. Rheumatology. 2008;47(4):530-4. doi: 10.1093/rheumatology/ken035
- Faurschou M, Obel N, Baslund B. High Risk of Pulmonary Embolism and Deep Venous Thrombosis but Not of Stroke in Granulomatosis With Polyangiitis (Wegener’s). Arthr Care Res. 2014;66(12):1910-4. doi: 10.1002/acr.22423
- Emmi G, Silvestri E, Squatrito D, et al. Thrombosis in vasculitis: from pathogenesis to treatment. Thrombosis J. 2015;13(1).doi: 10.1186/s12959-015-0047-z
- Макаров Е.А., Новиков П.И., Шевцова Т.П., и др. Венозные тромбоэмболические осложнения при АНЦА-ассоциированных васкулитах. Клиническая фармакология и терапия. 2017;26(3):37-42 [Makarov EA, Novikov PI, Shevtsova TP, et al. Venous thromboembolic complications in ANCA-associated vasculitis. Klinicheskaya farmakologiya i terapiya. 2017;26(3):37-42 (In Russ.)].
- Sousa ED, Smith R, Chaudhry A, et al. Venous thromboembolism with concurrent pulmonary haemorrhage in systemic vasculitis. Nephrol Dialys Transplant. 2012;27(12):4357-61. doi: 10.1093/ndt/gfs099
- Hilhorst M, Winckers K, Wilde B, et al. Patients with Antineutrophil Cytoplasmic Antibodies Associated Vasculitis in Remission Are Hypercoagulable. J Rheumatol. 2013;40(12):2012-46.doi: 10.3899/jrheum.130200
- Berden A, Nolan S, Morris H, et al. Anti-plasminogen antibodies compromise fibrinolysis and associate with renal histology in ANCA-associated vasculitis. J Am Soc Nephrol. 2010;21(12):2169-79.doi: 10.1681/asn.2010030274
- Nachman PH, Henderson AG. Pathogenesis of lung vasculitis. Seminars Respir Crit Care Med. 2011;32(3):245-53. doi: 10.1055/s-0031-1279822
- Hidalgo A, Chang J, Jang JE. Heterotypic interactions enabled by polarized neutrophil microdomains mediate thromboinflammatory injury. Nat Med. 2009;15(4):384-91. doi: 10.1038/nm.1939
- Angelillo-Scherrer A. Leukocyte-Derived Microparticles in Vascular Homeostasis. Circul Res. 2012;110(2):356-69. doi: 10.1161/circresaha.110.233403
- Huang Y-M, Wang H, Wang C, et al. Promotion of hypercoagulability in antineutrophil cytoplasmic antibody-associated vasculitis by C5a-induced tissue factor-expressing microparticles and neutrophil extracellular traps. Arthrit Rheumatol. 2015;67(10):2780-90.doi: 10.1002/art.39239
- Lara AR, Schwarz MI. Diffuse Alveolar Hemorrhage. Chest. 2010;137(5):1164-71. doi: 10.1378/chest.08-2084
- Fishbein G, Fishbein M. Lung Vasculitis and Alveolar Hemorrhage: Pathology. Seminars Respir Crit Care Med. 2011;32(3):254-63.doi: 10.1055/s-0031-1279823
- Franks TJ, Koss MN. Pulmonary capillaritis. Curr Opin Pulmon Med. 2000;6(5):430-5. doi: 10.1097/00063198-200009000-00008
- Wood J, Ellery P, Maroney S, et al. Biology of tissue factor pathway inhibitor. Blood. 2014;123(19):2934-43. doi: 10.1182/blood-2013-11-512764
- Heslet J, Nielsen J, Levi M, Johansson P. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care. 2006;10(6):177. doi: 10.1186/cc5132
- Cartin-Ceba R, Diaz-Caballero L, Al-Qadi MO, et al. Diffuse Alveolar Hemorrhage Secondary to Antineutrophil Cytoplasmic Antibody-Associated Vasculitis. Predictors of Respiratory Failure and Clinical Outcomes. Arthrit Rheumatol. 2016;68(6):1467-76.doi: 10.1002/art.39562
- Rolla G. Exhaled NO in diffuse alveolar haemorrhage. Thorax. 2005;60(7):614-5. doi: 10.1136/thx.2005.040287
- Brezina B, Jayne D. Plasma exchange and glucocorticoid dosing in anti-neutrophil cytoplasm antibody associated vasculitis: a randomized controlled trial. PEXIVAS. La Presse Médicale. 2013;42(4):772.doi: 10.1016/j.lpm.2013.02.285
- De Prost N, Parrot A, Cuquemelle E. Diffuse alveolar hemorrhage in immunocompetent patients: Etiologies and prognosis revisited. Respir Med. 2012;106(7):1021-32. doi: 10.1016/j.rmed.2012.03.015
- Ioachimescu OC, Stoller JK. Diffuse alveolar hemorrhage: diagnosing it and finding the cause. Cleveland Clin J Med. 2008;75(4):258-80.doi: 10.3949/ccjm.75.4.258
- Afonso M, Alfaro TM, Fernandes V, Cemlyn-Jones J. Diffuse alveolar hemorrhage – review of an interstitial lung disease clinic. Eur Respir J. 2017;50(61).
- Seror R, Pagnoux C, Ruivard M, et al. French Vasculitis Study Group. Treatment strategies and outcome of induction-refractory Wegener’s granulomatosis or microscopic polyangiitis: analysis of 32 patients with first-line induction-refractory disease in the WEGENT trial. Ann Rheumat Dis. 2010;69(12):2125-30.doi: 10.1136/ard.2010.131953
- Casian A, Jayne D. Management of Alveolar Hemorrhage in Lung Vasculitides. Seminars Respirat Crit Care Med. 2011;32(3):335-45.doi: 10.1055/s-0031-1279830
- Dreyer G, Fan S. Therapeutic Implications of Coexisting Severe Pulmonary Hemorrhage and Pulmonary Emboli in a Case of Wegener Granulomatosis. Am J Kidney Dis. 2009;53(5):e5-8.doi: 10.1053/j.ajkd.2008.12.022
- Tseng S-T, Tseng M-H, Huang J-L. Concurrent pulmonary hemorrhage and deep vein thrombosis in a child with ANCA-associated vasculitis: case report and review of literature. Pediatr Rheumatol. 2015;13(1):20. doi: 10.1186/s12969-015-0015-y
- Travis WD, Hoffman GS, Leavitt RY, et al. Surgical pathology of the lung in wegener’s granulomatosis. Review of 87 open lung biopsies from 67 patients. Am J Surg Pathol. 1991;15(4):315-33.doi: 10.1097/00000478-199104000-00001
- Mark EJ, Matsubara O, Tan-Liu NS, Fienberg R. The pulmonary biopsy in the early diagnosis of wegener’s (pathergic) granulomatosis: A study based on 35 open lung biopsies. Human Pathol. 1988;19(9):1065-71. doi: 10.1016/s0046-8177(88)80088-1
- Krause ML, Cartin-Ceba R, Specks U, Peikert T. Update on Diffuse Alveolar Hemorrhage and Pulmonary Vasculitis. Immunol Allergy Clin North Am. 2012;32(4):587–600. doi: 10.1016/j.iac.2012.08.001
- Zagorski J, Debelak J, Gellar M, et al. Chemokines Accumulate in the Lungs of Rats with Severe Pulmonary Embolism Induced by Polystyrene Microspheres. J Immunol. 2003;171(10):5529-36.doi: 10.4049/jimmunol.171.10.5529
- Kinoshita Y, Sakamoto A, Koga T, Midaka K. Diffuse alveolar damage associated with pulmonary thromboembolism. Respir Med Case Rep. 2013;8:25-7. doi: 10.1016/j.rmcr.2012.12.005
- Stone JH, Merkel PA, Spiera R, Seo P. Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis. N Eng J Med. 2010;363(3):221-32. doi: 10.1056/nejmoa0909905
- Yates M, Watts RA, Bjema IM, et al. EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis. Ann Rheumat Dis. 2016;75(9):583-94. doi: 10.1136/annrheumdis-2016-209133
- Pusey C, Hamour S, Salama AD. Management of ANCA-associated vasculitis: Current trends and future prospects. Therap Clin Risk Manag. 2010;6:253-64. doi: 10.2147/tcrm.s6112
- Miloslavsky EM, Specks U, Merkel PA, et al. Rituximab for the Treatment of Relapses in ANCA-associated Vasculitis. Arthrit Rheumatol. 2014;66(11):3151-9. doi: 10.1002/art.38788
- Frausová D, Hrušková Z, Lánská V, Lachmanova J. Long-term outcome of patients with ANCA-associated vasculitis treated with plasma exchange: a retrospective, single-centre study. Arthrit Res Ther. 2016;18(1):168. doi: 10.1186/s13075-016-1055-5
- Winters J. Plasma exchange: concepts, mechanisms, and an overview of the American Society for Apheresis guidelines. Hematology. 2012;2012:7-12.
- Kaplan AA. A simple and accurate method for prescribing plasma exchange. ASAIO Trans. 1990;36:M597-9.
- Szpir WM. Plasma exchange in antineutrophil cytoplasmic antibody-associated vasculitis – a 25-year perspective. Nephrol Dialys Transplant. 2015;30:i146-9. doi: 10.1093/ndt/gfv051
- Heslet L, Nielsen J, Levi M, et al. Successful pulmonary administration of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care. 2006;10(6):R177. doi: 10.1186/cc5132
- Park JA, Kim B-J. Intrapulmonary Recombinant Factor VIIa for Diffuse Alveolar Hemorrhage in Children. Pediatrics. 2015;135(1):e216-20.doi: 10.1542/peds.2014-1782
- Okamoto S, Okamoto U. Amino-methyl-cyclohexane-carboxylic acid: AMCHA. Keio J Med. 1962;11(3):105-5. doi: 10.2302/kjm.11.105
- Okamoto S, Sato S, Takada Y, Okamoto U. An active stereoisomer (trans-form) of AMCHA and its antifibrinolytic (anti-plasminic) action in vitro and in vivo. Keio J Med. 1964;13(4):177-85.doi: 10.2302/kjm.13.177
- Nilsson IM. Clinical pharmacology of aminocaproic and tranexamic acids. J Clin Pathol. 1980;33(14):41-7. doi: 10.1136/jcp.33.suppl_14.41
- Verma K, Errico TJ, Vaz KM, Lonner BS. A prospective, randomized, double-blinded single-site control study comparing blood loss prevention of tranexamic acid (TXA) to epsilon aminocaproic acid (EACA) for corrective spinal surgery. BMC Surgery. 2010;10:13.doi: 10.1186/1471-2482-10-13
- Solomonov A, Fruchte O, Zuckerman T, Brenner B. Pulmonary hemorrhage: A novel mode of therapy. Respir Med. 2009;103(8):1196-200. doi: 10.1016/j.rmed.2009.02.004
- Khan SA, Subla MR, Behl D, et al. Outcome of patients with small-vessel vasculitis admitted to a medical ICU. Chest. 2007;131(4):972-6.doi: 10.1378/chest.06-2464
- Stegeman CA, Tervaert JWC, De Jong PE, Kallenberg CGM. Trimethoprim-sulfamethoxazole (Co-Trimoxazole) for the prevention of relapses of Wegener’s granulomatosis. N Eng J Med. 1996;335(1):16-20.doi: 10.1056/nejm199607043350103
- McAdoo SP, Medjeral-Thomas N, Gopaluni S, et al. Long-term follow-up of a combined rituximab and cyclophosphamide regimen in renal anti-neutrophil cytoplasm antibody-associated vasculitis. Nephrol Dialys Transplant. 2018;33(5):1-11. doi: 10.1093/ndt/gfy075
- Gavranic BB, Basic-Jukic N, Premuzic V, Kes P. Membrane therapeutic plasma exchange with and without heparin anticoagulation. J Clin Apheresis. 2017;32(6):479-85. doi: 10.1002/jca.21544
- Puppe B, Kingdon EJ. Membrane and centrifugal therapeutic plasma exchange: practical difficulties in anticoagulating the extracorporeal circuit. Clin Kidney J. 2014;7(2):201-5. doi: 10.1093/ckj/sft163
- Lee G, Arepally GM. Anticoagulation Techniques in Apheresis: From Heparin to Citrate and Beyond. J Clin Apheresis. 2012;27(3):117-25. doi: 10.1002/jca.21222
- Rayment JH, Cutz E, Levy DM, Dell SD. Concomitant Diffuse Alveolar Hemorrhage and Pulmonary Embolism in a Child with Isolated Pulmonary Capillaritis. Ann Am Thorac Soc. 2017;14(3):470-3.doi: 10.1513/annalsats.201610-783le